it's all in the RNSs
there is zero volume because
zero interest, because
zero progress, and because (almost)
zero sales, because
zero (sorry, "almost") demand from consumers for overpriced repackaged CBG/D beauty products
zero when it comes to strategy,
zero when it comes to launching new products
and soon to be
zero cash.
None of this matters to Candle. Because CBX shall live long and prosper, regardless of...well, anything really!
I think we should redo the sweepstakes about the upcoming equity raise after the next trading update. Just to give punters a second chance :)
Those who feel that they don't know, but are keen and eager to learn, very quickly become wiser and more knowledgeable than those who think they know it all. The former progress, while the latter stagnate (and therefor regress).
Look at the context, Candle: why would Google and Meta take the slightest risk with allowing advertising for dubious products. Imagine someone has a negative reaction to CBX product, having bought the product following an advert on their platform....they wouldn't hear the end of it! The press would be all over it.
And for what...for that tiny bit of advertising revenues? Yes, what ever CBX will spend is nothing more "than a fiver" to their advertising revenues. So why would they take any changes with CBD/G?
"Just demonstrate to the health authorities that you products are safe and effective. Then we will talk again".
What else do we expect them to say?!
Candle doesn't worry about anything: things like cashflow, competition, a sensible strategy....peanuts to candle. CBX will live long and prosper, no matter what.
The market is growing? Yes, the part of the market where CBX's products are suspended is. The part they are obsessed about, beauty, isn't.
The competition their is humongous (not an issue for Candle, I know) with massive brands and tonnes of challenger brands.
Re the RNS: typical of CBX, I find. Google and Meta will not allow paid advertising (organic searches allowed, so they could invest in SEO) because of what regulators say in a certain country. It's all to do with lack of scientific evidence that they are safe and healthy. Why would they take any chances with their billions of advertising revenues for the sake of CBX's advertising spend, which will amount to a
fiver
depends on (a) how money the company wants to raise and (b) how much money current investors want to fork out. They may need to look beyond current investors, particularly if past performance and future plans aren't very convincing
yes
Now, now, now, Windows. Don't wind them more than you have to.
A cash shell is indeed an option for many failed companies but it's, even for me, too soon.
CBD/G offers lots of potential. Just not in Beauty; that really is the daftest thing I have ever heard.
Change strategy; new CEO and restart. I think they have about 3-6 months to pull this off. It ain't rocket science, they just got to JFDI.
Failing that, a predictable equity raise, followed by predictable failures and ultimately...yes, a cash shell could be a good option. She's could just be part of a winning company. Fancy that for a change!
they might surprise us all and do a placing much earlier than anticipated. Assuming the financial results are not material enough to offset current cash burn. (I know some peeps here think cash is not important, lol. Bless 'm)
A sister airline of British Airways has put in the first big order for a new generation of helium airships from a venture backed by Iron Maiden frontman Bruce Dickinson.
Valencia-based Air Nostrum, owned by British Airways’ holding company IAG, has struck a deal to buy ten airships from Bedfordshire-based Hybrid Air Vehicles.
Air Nostrum is hoping to have the 100-seat vehicles running on its regional, short-haul routes as soon as 2026.
The deal could be worth more than $600m including leasing the aircraft and maintenance, according to insiders.
Business secretary Kwasi Kwarteng hailed the deal as “proof of how the UK’s businesses are embracing new technology to drive growth and support high skilled UK jobs.”
Hybrid Air Vehicles’ Airlander 10 is slower than traditional jets, but much more efficient, aiming to slash the carbon output per passenger by 90pc. Slashing carbon output will also make the trips cheaper as fuel expenses are cut.
Sounds about right.
Maybe there are more people not buying into the CBX strategy...
*know
I particularly struggle to understand why Candlesticks is digging his heals in again.
Btw, any astute business leader will be mindful of cashflow and therefore want to negotiate better payment terms then "everything upfront".
I some diehards don't get that cashflow is king, but for the more sensible ones amongst us, this is another example of poor management. Even if CBX is tiny, there are more astute ways available but this BOD doesn't come across as particularly streetwise, IMHO
"I have a pet hate though for people who just say - This is going to pop, MM holding it back, buyers are loading up and then don’t back that up with anything :-)"
I know, it is so infantile!! I cringe each time I see this. Again, it is either incompetence (they don't know any better and it's easier to blame the MMs rather then the BOD), or dishonesty. I have seen this happen before, peeps writing these things to give people a false sense of security. Very nasty. "Gollum, Gollum!"
this post tells me you are simply either dishonest or incompetent.
"Slow, very slowly"
Had a look on Amazon to see what the noise is about. Two things hit me:
1. We are talking about 30-40 reviews per CG product
2. Tiny in comparison to product containing Hyaluronic Acid, where we are literally talking about tens fo thousands of reviews.
Shows you scale of what CBX is up against.
Not just in numbers, but also the marketing challenge is enormous: why on earth CBD/G instead of Hyaluronic Acid for example. Swimming against the tide doesn't even beging to desribe it. I think the whole product strategy of CBX is absolute madness (but I may have said this before, lol)
The increase in cash burn per month is a concern, particularly in light of the flop that was the "soft launch".
And we also know that with marketing investment done during Q2, and the hires they have done, that the increasing trend cash burn can only continue. That is so plainly to see that quite frankly arguing about it is a little bit silly, IMHO.
Sales needs to be ramped up far beyond the capabilities of CBX to hit break even.
That does not mean it's the end of CBX; certainly not. It simply means there will be an equity raise. Now, if they spend that money wisely and get to grow the business, then this raise could be great.
However, CBX will need a convincing strategy to show what they are going to do differently with the cash to turnaround fortunes.
*broken